Spruce Biosciences recently announced that its candidate drug TA-ERT for Sanfilippo syndrome type B (also known as MPS IIIB) received positive feedback during a Type B meeting with the U.S. Food and Drug Administration (FDA).
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
The meeting focused on discussing the clinical development plan for the drug. Both parties reached an important consensus on the subsequent trial protocol, laying a solid foundation for advancing the research and development process of TA-ERT.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Wang Chun deposited 9,937 ETH and 147.5 WBTC withdrawn from an exchange into Spark
ForesightNews•2026/06/26 10:00
Trending news
MoreCrypto prices
More
Bitcoin
BTC
$59,661.76
-3.13%
Ethereum
ETH
$1,552.11
-5.71%
Tether USDt
USDT
$0.9986
+0.01%
USDC
USDC
$0.9997
+0.00%
XRP
XRP
$1.03
-4.40%
Solana
SOL
$69.02
+0.43%
TRON
TRX
$0.3217
-2.17%
Hyperliquid
HYPE
$62.34
-2.10%
Dogecoin
DOGE
$0.07395
-3.73%
Zcash
ZEC
$400.15
-3.71%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now